Atlas Trials

To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients

Clinical trial NCT03017313 · COMPLETED

Trial details

NCT number
NCT03017313
Sponsor
Ipsen
Status
COMPLETED
Study type
OBSERVATIONAL
Prostate Cancer
Start date
2017-07-13
Primary completion
2021-06-14
Enrollment
510

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.